πŸ‡ΊπŸ‡Έ FDA
Patent

US 11753628

HSD17B13 variants and uses thereof

granted A61KA61K31/713A61K38/443

Quick answer

US patent 11753628 (HSD17B13 variants and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/713, A61K38/443, A61K38/465, A61K47/61